Hans Peter Bøhn

Bøhn manages a charitable trust for the benefit of medical research. He has 12 years’ experience from investment banking, related to the life science industries. Prior to this, he worked in various positions in Nycomed ASA, a pharmaceutical company specialised in contrast media for diagnostic imaging. He is a qualified medical doctor, with a postgraduate diploma in pharmaceutical medicine (UK). Bøhn is Chairman of PCI Biotech. He joined the Board of SpinChip in 2014.